PKCα mediated induction of miR-101 in human hepatoma HepG2 cells

被引:43
|
作者
Chiang, Chao-Wei [1 ]
Huang, Yi [2 ]
Leong, Ka-Wai [2 ]
Chen, Lih-Chyang [3 ]
Chen, Hua-Chien [4 ]
Chen, Shu-Jen [4 ]
Chou, Chen-Kung [1 ,2 ]
机构
[1] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan
[2] Chang Gung Univ, Grad Inst Basic Med Sci, Dept Life Sci, Tao Yuan, Taiwan
[3] Chang Gung Univ, Chang Gung Mol Med Res Ctr, Tao Yuan, Taiwan
[4] Chang Gung Univ, Mol Med Res Ctr, Genom Core Lab, Tao Yuan, Taiwan
关键词
PROTEIN-KINASE-C; HEPATOCELLULAR-CARCINOMA; GROWTH-INHIBITION; EPITHELIAL-CELLS; TUMOR-SUPPRESSOR; CANCER; MICRORNA-101; ACTIVATION; EXPRESSION; MECHANISM;
D O I
10.1186/1423-0127-17-35
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Protein Kinase C (PKC) is a serine/threonine kinase that involved in controlling of many cellular processes such as cell proliferation and differentiation. We have observed previously that TPA (12-O-tetradecanoylphorbol 13-acetate) induces cell cycle arrest in G0/G1 phase in human hepatoma HepG2 cells. However, is there any miRNA involved in PKCa mediated cell growth arrest is still unknown. Methods: We first surveyed 270 miRNA expression profiles in 20 pairs of human hepatoma tissues. We identified 11 up-regulated and 23 down-regulated miRNAs (FDR < = 0.01; fold-change > = 2) in human hepatoma tissue after Student's T-test and Mann-Whitney rank test. We then examined miRNAs expression profile in TPA treated HepG2 cells. Two miRNAs, miR-101, and miR-29c, were shown to be significantly down regulated in human hepatoma tissues and induced over 4-fold in HepG2 cells under TPA treatment. Results: In this study, we examined TPA regulated miRNA expression profile in human hepatoma HepG2 cells. We identified two miRNAs, 101 and 29c, were induced by TPA and down regulated in human hepatoma tissues suggest that they might play as tumor suppressor gene and in tumor formation of HCC. Since induction kinetics of miR-101 by TPA was much faster than miR-29c suggests that the induction of miR-101 may be the primary response of TPA treatment. We then further investigated how miR-101 was regulated by TPA. MiR-101 targets two subunits of PRC2 complex, enhancer of zeste homolog 2 (EZH2) and EED, and was shown to play as a tumor suppressor gene in human prostate, breast and liver cancers. The target sequence of miR-101 located in the 3' UTR of both EZH2 and EED's mRNA was identified by bioinformatic analysis and was validated by reporter luciferase activity assay. Then we showed that TPA not only up regulated miR-101 expression, but also reduced protein level of EZH2, EED and H3K27me3 in HepG2 cells. Using lenti-virus-mediated shRNA to knockdown endogenous PKCa expression, we observed that TPA induced growth arrest, elevation of miR-101 and reduction of EZH2, EED and H3K27me3 proteins were all PKCa dependent. Specific inhibitor of ERK completely blocked TPA induced miR-101 expression. Conclusions: Therefore, this is the first time to show that PKCa and ERK pathway play important role to activate miR-101 expression, reduce PRC2 complex and H3K27me3 level. This epigenetic regulatory pathway may represent a novel mechanism of carcinogenesis and deserve further investigation.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Induction of apoptosis by Xiakemycin A in human hepatoma HepG2 cells
    Chen, Chuan
    Han, Zhu
    Yang, Minjie
    Jiang, Zhongke
    Ou, Xiuyuan
    MEDICINE, 2020, 99 (17) : E19848
  • [2] Anticancer effects of Gardenia jasminoides in HepG2 human hepatoma cells
    Chen, Shao-cheng
    Zhao, Xin
    Yi, Ruo-kun
    Qian, Jun
    Shi, Yan-hong
    Wang, Rui
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (02): : 716 - 726
  • [3] Flavone Induces Cell Death in Human Hepatoma HepG2 Cells
    Valdameri, Glaucio
    Kenski, Juliana C. N.
    Moure, Vivian R.
    Trombetta-Lima, Marina
    Martinez, Glaucia R.
    Sogayar, Mari C.
    Winnischofer, Sheila M. B.
    Rocha, Maria E. M.
    NATURAL PRODUCT COMMUNICATIONS, 2014, 9 (10) : 1457 - 1460
  • [4] MIR-21 ON PROLIFERATION IN HEPATOMA HEPG2 CELLS
    Deng, Xuesong
    Cheng, Jun
    Zhan, Naiyang
    Chen, Janwei
    Zhan, Yongqiang
    Ni, Yong
    Liao, CaiXian
    ACTA MEDICA MEDITERRANEA, 2022, 38 (04): : 2517 - 2525
  • [5] Electrophoretic behaviors of human hepatoma HepG2 cells
    Hsu, Jyh-Ping
    Ku, Ming-Hong
    Yang, Li-Chia
    Lu, Jui-Nan
    Youny, Tai-Horng
    Tseng, Shiojenn
    ELECTROPHORESIS, 2009, 30 (09) : 1531 - 1537
  • [6] In vitro cytotoxicity and induction of apoptosis by silica nanoparticles in human HepG2 hepatoma cells
    Lu, Xun
    Qian, Jiangchao
    Zhou, Huanjun
    Gan, Qi
    Tang, Wei
    Lu, Jingxiong
    Yuan, Yuan
    Liu, Changsheng
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2011, 6 : 1889 - 1901
  • [7] Capsaicin-induced Apoptosis in Human Hepatoma HepG2 Cells
    Huang, Shang-Pang
    Chen, Jung-Chou
    Wu, Chih-Chung
    Chen, Chi-Tsai
    Tang, Nou-Ying
    Ho, Yung-Tsuan
    Lo, Chyi
    Lin, Jink-Pin
    Chung, Jing-Gung
    Lin, Jaung-Geng
    ANTICANCER RESEARCH, 2009, 29 (01) : 165 - 174
  • [8] Potentiation of resveratrol-induced apoptosis by matrine in human hepatoma HepG2 cells
    Ou, Xiuyuan
    Chen, Yan
    Cheng, Xinxin
    Zhang, Xumeng
    He, Qiyang
    ONCOLOGY REPORTS, 2014, 32 (06) : 2803 - 2809
  • [9] Dihydroartemisinin induces endoplasmic reticulum stress-mediated apoptosis in HepG2 human hepatoma cells
    Gao, Xiaoling
    Luo, Ziguo
    Xiang, Tingxiu
    Wang, Kejian
    Li, Jian
    Wang, Pilong
    TUMORI, 2011, 97 (06) : 771 - 780
  • [10] A polysaccharide from Andrographis paniculata induces mitochondrial-mediated apoptosis in human hepatoma cell line (HepG2)
    Zou, Yanmei
    Xiong, Hua
    Xiong, Huihua
    Lu, Tao
    Zhu, Feng
    Luo, Zhiyong
    Yuan, Xianglin
    Wang, Yihua
    TUMOR BIOLOGY, 2015, 36 (07) : 5179 - 5186